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Abstract
Introduction: The pathogenesis of juvenile idiopathic arthritis (JIA) is not fully understood. Recently the present authors
described disturbed apoptosis of JIA lymphocytes in both peripheral blood (PB) and synovial fluid (SF) as well as an abnor-
mal distribution of blood dendritic cells (BDCs) between the PB and SF in this disease. Possible relationships between these
events during the development of JIA process are assessed here. 
Materials and Methods: Lymphocyte apoptosis and BDC counts were assessed in the PB and SF of untreated JIA children.
Lymphocyte apoptosis was analyzed by the Annexin-V/propydium iodide assay. Total DC (TDC) number was based on the
sum of three BDC subpopulations determined using a panel of monoclonal antibodies against BDC antigens (BDCA):
myeloid type 1 (mDC1, BDCA-1+/HLA-DR+/CD19–), myeloid type 2 (mDC2, BDCA-3+/HLA-DR+/CD14–), and plasma-
cytoid (pDC, BDCA-2+/HLA-DR+/CD123+). Cells were enumerated by the flow cytometric “single-platform” method. The
concentration of tumor necrosis factor (TNF)-α and the distribution of particular lymphocyte subtypes in both PB and SF
were also investigated. 
Results: There was significant positive correlation between apoptosis of PB lymphocytes and SF TDC count (p=0.002) as
well as SF TNF-α concentration (p=0.007). SF TNF-α levels also correlated with SF TDC count (p=0.003). Moreover, JIA
SF was distinctly enriched with CD4+ and CD8+ T lymphocytes and included CD4+/CD25high cells as well. There was signif-
icant positive correlation between the number of CD4+/CD25high cells and SF JIA BDC count (p=0.015). 
Conclusions: These data suggest a possible link between impaired apoptosis of PB/SF lymphocytes and increased recruitment
of PB BDCs to SF and other elements of the immune system in JIA, including regulatory CD4+/CD25high cells.
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INTRODUCTION
The pathogenesis of juvenile idiopathic arthritis
(JIA) is still a matter of extensive investigation.
Similarly to adult rheumatoid arthritis (RA), autoreac-
tive T lymphocytes most probably play the key role in
the initiation of this inflammatory process [2, 4]. After
contact with antigen-presenting cells (APCs) they
become activated and induce the response of B lympho-
cytes and monocytes/macrophages and the secretion of
auto-antibodies and several inflammatory cytokines
(e.g. tumor necrosis factor (TNF)-α and interleukin
(IL)-1, -6, and -8). This in turn stimulates the activation
of fibroblasts and chondrocytes and the release of carti-
lage-degrading enzymes [2, 15, 28].
Our previous studies showed that lymphocytes from
peripheral blood and synovial fluid (SF) are character-
ized by impaired apoptosis [23–25]. We found increased
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[23], but the apoptosis of lymphocytes present in JIA SF
was significantly inhibited [25]. This phenomenon likely
reflects some key events in the pathogenesis of the
disease.
Some studies, including our most recent report, sug-
gested that dendritic cells (DCs) can be an important
link in the pathogenic chain of JIA [9, 11, 14, 26]. DCs
are specialized APCs which circulate via the blood to
different tissues where, after maturation, they initiate
and regulate T- and B-cell responses [12]. Based on spe-
cific antigens (blood DC antigens, BDCA-1, -2, and -3),
circulating DCs (blood DCs, BDCs) can be divided into
three subsets [8, 20]. These are plasmacytoid BDCA-2+
DCs (pDCs) and two myeloid subsets, mDC1 (BDCA-
-1+) and mDC2 (BDCA-3+) [6, 7, 10, 20]. pDCs typical-
ly produce interferon (IFN)-α [9]. Moreover, activated
pDCs produce IFN-γ and TNF-α [3, 9] and express Toll-
-like receptors (TLR)7 and 9 [7]. Both the mDC1 and
mDC2 subtypes were shown to release proinflammatory
cytokines (e.g. TNF-α, IFN-1β, -6, and -8) in response to
TLR2 and TLR4 stimulation; however mDC1 cells are
much stronger inducers of T-cell proliferation than
mDC2 [7]. 
Little is known about BDCs in JIA. One report
assessed BDCA-2+/CD123+ and CD11c+ DCs in JIA
children [9]. Furthermore, we found deficiency in all
subtypes of peripheral blood BDCs (pDC, mDC1,
mDC2) which was accompanied by SF enrichment with
these cells [24]. Circulating BDCs probably migrate to
the joints and participate there in the development of an
autoimmune response. In the present study we analyzed
the potential relationship between impaired apoptosis
of lymphocytes and the distribution of DCs in peripher-
al blood and SF of children with JIA.
MATERIALS AND METHODS
Patients
The study was performed with 25 previously untreat-
ed children with JIA, including 15 girls and 10 boys
(median age: 12.5 years, range: 3–17 years). The diagno-
sis was established according to Durban’s criteria [21].
Three stages of JIA activity were also distinguished based
on clinical and laboratory criteria, namely low activity
(joint movement limited without pain or swelling, no
extra-articular symptoms, ESR<20 mm/1st-h, CRP<10
mg/l), moderate activity (moderate intensity of arthritis,
and/or slight temperature, ESR 20–60 mm/1st-h, CRP
10–30 mg/l), and high activity (morning stiffness, pain
and/or swelling of joints, and/or hepatosplenomegaly,
fever, rash, and raised values for laboratory tests
ESR>60 mm/1 st-h, CRP>30 mg/l). Moreover, three
types of JIA onset were distinguished: polyarticular,
oligoarticular, and systemic disease. The study was con-
ducted in accordance with the Helsinki Declaration and
was approved by the local ethics committee. 
Immunophenotyping
For BDC assessment, peripheral blood samples
(n=25) were collected during routine laboratory investi-
gations. Moreover, BDCs were detected in SF samples
(n=15) obtained during therapeutic biopsy in case of
joint involvement. Peripheral blood samples were collect-
ed on the day of the joint biopsy. Cell immunophenotype
was determined using a panel of monoclonal antibodies
(MoAbs) directed against BDC-specific antigens: fluo-
rescein isothiocyanate (FITC)-conjugated BDCA-1,
BDCA-2, and BDCA-3 (Miltenyi Biotec, Germany), phy-
coerithrin-conjugated CD14, CD19 (Caltag Laboratories,
USA), and CD123 (Miltenyi Biotec, Germany), as well as
three-color-conjugated HLA-DR (Caltag Laboratories,
USA). Additionally, several lineage-specific antigens,
such as CD3, CD4, CD8, CD19, and CD25, were detect-
ed for additional discrimination of particular leukocyte
subpopulations (Becton Dickinson, USA). The
immunophenotype was assessed by four-color flow
cytometry (FACScan, Becton-Dickinson, USA) and ana-
lyzed with standard emission filters (FL1-FL4). 
Assessment of BDC counts 
The number of BDCs was assessed by the “single-
-platform” method. Fifty µl of whole blood was added
directly to TruCOUNT tubes (Becton Dickinson, USA)
containing a known number of fluorescent beads. FACS
Lysing Solution (Becton Dickinson, USA) was subse-
quently added to lyse and thereby eliminate interfering
red blood cells (the “lyse-no wash” method). Then the
respective MoAbs were added to the tubes for detecting
the particular DC antigens. In each sample, 100,000
cells were measured. The absolute DC number (cells/µl)
was determined by comparing the number of cellular
events to bead events, i.e. the number of measured DCs
was divided by the number of fluorescence beads and
multiplied by the TruCOUNT bead concentration.
Results were presented as the number of peripheral
blood BDCs or SF BDCs per µl. 
BDCs were gated from the population of lympho-
cytes and monocytes based on the side-scatter (SSC) vs.
forward-scatter (FSC) distribution. Then three subpop-
ulations of BDCs were discriminated among the HLA-
-DR+ cells from the mononuclear cell gate. These were
two myeloid types, mDC1(BDCA-1+/CD19–/HLA-
-DR+) and mDC2 (BDCA-3+/CD14–/HLA-DR+). The
third subpopulation, pDC, was detected based on the
BDCA-2+/CD123+/HLA-DR+ immunophenotype. The
total DC (TDC) count was calculated as the sum of
these three BDC subpopulations.
Assessment of apoptosis
Mononuclear cells were also isolated from
heparinized peripheral blood or SF samples to assess
apoptosis. The samples were centrifuged in Histopaque-
1077 (Sigma Diagnostics, USA) density gradient. The
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(HBSS, Biomed, Poland) was layered on top of the
Histopaque media in centrifuge tubes and centrifuged
for 30 min at 200×g. The interphase region containing
peripheral blood mononuclear cells was collected and
then washed twice in HBSS and RPMI 1640 medium.
The cells were then divided and re-suspended in phos-
phate-buffered saline (PBS, Sigma-Aldrich Chemie
GmbH, Germany) for the apoptosis evaluation.
Apoptosis was assessed by detection of phosphatidylser-
ine externalization in the cell membrane using the
Annexin-V (Ann-V)/propydium iodide (PI) assay. In
brief, cells were washed twice with PBS and then resus-
pended in 100 µl of binding buffer containing 2 µl of
FITC-conjugated Ann-V and 10 µg/ml of PI (Becton
Dickinson, USA). The samples were then incubated for
15 min at room temperature in the dark and fluorescence
was measured by flow cytometry. Lymphocytes were
gated from the mononuclear cell population based on the
SSC vs. FSC distribution. The apoptotic index (AI) was
calculated as the percentage of Ann-V+ lymphocytes. 
Measurement of TNF-α concentration
The concentration of TNF-α was also measured in
both the serum and SF of the JIA children by a standard
immunoenzymatic (ELISA) method (R&D Systems,
USA). 
Statistics
For the statistical analysis of the data, non-paramet-
ric Mann-Whitney or Wilcoxon pair tests were used for
comparison of the results. Correlation between features
was evaluated using the Spearman R-test. Comparisons
and correlations were considered significant at a p level
<0.05. 
RESULTS
The characteristics of the examined group of JIA
children are shown in Table 1. The activity of the disease
was considered low in 9, moderate in 7, and high in 9 JIA
children. Ten children were found to have oligoarticular,
12 polyarticular, and 3 systemic disease type of onset.
Abnormal anti-nuclear antibodies levels were detected
in 7 JIA children with oligoarticular and in 1 with sys-
temic disease. Rheumatoid factor-positive was found
only in 4 children, all with polyarticular type of onset.
Apoptosis of peripheral blood and SF lymphocytes in JIA
Apoptosis of peripheral blood lymphocytes was sig-
nificantly higher than in SF of the JIA children
(p<0.0001); median AI in peripheral blood lymphocytes
was 5.9% (range: 1.2–12.3%) and in SF 0.9% (range:
0.1–3.4%; Fig. 1). 
Differences in the number of BDCs in peripheral blood
and SF of the JIA children
The mean number of TDCs in JIA SF was signifi-
cantly higher than in the peripheral blood of the JIA
children. This concerned TDC count (p<0.0001) as well
as all the subtypes mDC1 (p<0.0001), mDC2
(p<0.0001), and pDC (p=0.007; Table 2).
Correlation between peripheral blood lymphocyte 
apoptosis and BDC counts in JIA 
The level of spontaneous apoptosis of JIA peripher-
al blood lymphocytes correlated positively with the
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Table 1. Clinical and laboratory characteristics of the chil-
dren with JIA 
Characteristics No. of patients (%) 
of JIA children or median (range)
Total number 25
Gender 15  girls (60%), 10 boys (40%)
Age  12.5 (3–17) years
Activity of the disease 
low 9 (36%) 
moderate 7 (28%)
high 9 (36%)
Type of onset 
systemic disease 3 (12%)
polyarthritis 12 (48%)
oligoarthritis 10 (40%)
Leukocytes (109/l) 8.5  (3.8–22.5)
Platelets (109/l) 350.0  (210.0–530.0)
Erythrocyte sedimentation  22.5 (4–90)
ratio/1st-h
Serum C-reactive protein  1.9 (0.01–12.4)
(ng/ml) 
Rheumatoid factor  4 patients (16%)
Antinuclear antibodies  8 patients (32%)
Fig. 1. Differences in apoptosis of peripheral blood (PB) lympho-
cytes in PB and synovial fluid (SF) from children with JIA.
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druk-8.qxd  7/25/08 11:32 AM  Page 285number of TDCs in SF (R=0.74, p=0.002; Fig. 2). In
contrast, higher peripheral blood lymphocyte apoptosis
was associated with more profound depletion of TDCs
in JIA peripheral blood; however, this correlation did
not reach statistical significance (R=–0.35, p=0.101;
Fig. 3). There was also a distinct tendency towards neg-
ative correlation between the rate of SF lymphocyte
apoptosis and SF TDC count (R=–0.54, p=0.070; 
Fig. 4).
Serum and SF levels of TNF-α in the children 
with JIA
Levels of TNF-α in SF were significantly higher than
in serum of the JIA children (p<0.0001). Median TNF-α
level in serum was 7.8 pg/ml (3.1–82.7 pg/ml) and in SF
as high as 199.5 pg/ml (range: 16.8–376.5 pg/ml; Fig. 5).
Spontaneous apoptosis of peripheral blood lymphocytes
correlated positively with the level of TNF-α in SF of
children with JIA (R=0.66, p=0.007; Fig. 6A).
Importantly, moreover, SF concentrations of TNF-α cor-
related significantly with SF TDC counts (R=0.81,
p=0.003; Fig. 6B). 
Distribution of lymphocytes in peripheral blood 
and SF JIA compartments
The absolute numbers of different T-lymphocyte
subtypes, including CD4+ and CD8+ cells, were higher
in SF than in peripheral blood of JIA children (p=0.016
and 0.023, respectively; Table 3). In contrast, CD19+
B-cell counts were significantly lower in SF than in
peripheral blood of JIA children (p=0.006). Moreover,
a significant prevalence of the population of
CD4+/CD25high cells was found in JIA SF (p=0.026;
Table 3). Interestingly, the number of SF
CD4+/CD25high cells correlated with SF TDC count
(R=0.68, p=0.015; Fig. 7). There was no statistically sig-
nificant correlation between TDC counts and T- or 
B-cell numbers in SF of the JIA children.
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Table 2. Comparison of the absolute numbers of blood den-
dritic cells (BDCs) and their subpopulations in peripheral
blood (PB) and synovial fluid (SF) of the children with JIA
BDC PB SF p value
(cells/µl) n=25 n=15
TDC  29.7 (9.4–205.6) 602.3 (132.6–3565.6) <0.0001
mDC1 20.8  (5.7–128.0) 246.2  (42.1–1761.0) <0.0001
mDC2 2.4  (0.7–46.6) 151.6  (33.8–1305.5) <0.0001
pDC 6.5  (0.7–92.3) 204.5 (11.4–2925.5) =0.007
TDC – total absolute number of BDCs, mDC – myeloid BDCs,
pDC – plasmacytoid BDCs. Medians and ranges are shown.
Fig. 2. Correlation between apoptosis of peripheral blood (PB)
lymphocytes and the total number of dendritic cells (TDCs) in syn-
ovial fluid (SF). 
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Fig. 3. Correlation between lymphocyte apoptosis and the total
number of DCs (TDCs) in peripheral blood (PB) in JIA.
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Fig. 4. Correlation between the rate of synovial fluid (SF) lympho-
cyte apoptosis and the total number of SF DCs (TDCs).
R coeficient =–0.54, p=0.070
-0.5 0.0 0.5 1.0 1.5 2.0 2.5 3.0 3.5 4.0
Apoptosis of SF lymphocytes (%)
-500
0
500
1000
1500
2000
2500
3000
3500
4000
T
D
C
c
o
u
n
t
s
i
n
S
F
(
c
e
l
l
/
µ
l
)
druk-8.qxd  7/25/08 11:32 AM  Page 286DISCUSSION
In this study we provide for the first time evidence of
relationships between abnormalities in impaired lym-
phocyte apoptosis and disturbed distribution of BDCs in
children with JIA. This finding may have an important
implication for a better understanding of the pathogen-
esis of JIA. Previously we showed that apoptosis of
peripheral blood JIA lymphocytes is enhanced com-
pared with that of peripheral blood lymphocytes from
healthy children [23]. On the other hand, we found that
apoptosis of lymphocytes in JIA SF was significantly
inhibited in comparison with spontaneous apoptosis
occurring in healthy controls [24, 25]. Very recently we
described a deficiency in all subtypes of peripheral
blood BDCs in children with JIA and simultaneous
enrichment of JIA in these cells, with evidence of their
better differentiation and maturation within JIA SF
[26]. 
This study showed significant positive correlation
between enhanced apoptosis of lymphocytes in periph-
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Fig. 5. Differences in concentration of TNF-α in serum and syn-
ovial fluid (SF) from children with JIA.
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Fig. 6. Correlation between synovial fluid (SF) TNF-α concentra-
tion and apoptosis of peripheral blood (PB) lymphocytes or the total
number of dendritic cells (TDCs) in children with JIA: A – SF
TNF-α concentration vs. PB lymphocytes apoptosis; B – SF TNF-
α concentration vs. SF TDC counts. 
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Table 3. Comparison of the absolute numbers of different
subpopulations of lymphocytes in peripheral blood (PB) and
synovial fluid (SF) of the children with JIA
Cell count PB  SF p value
(cell/µl) n=25 n=15
CD3+ 2717.9 12085.2 0.027
(1445.1–22056.2) (3444.3–12085.2)
CD4+ 1827.8 8514.4 
(820.4– 18501.7) (2593.7–113213.9) 0.016
CD8+ 1045.0 2377.8 
(404.4– 6827.8) (858.7–29641.9) 0.023
CD4+/ 61.7 540.2  0.026
/CD25high (9.7–239.9) (48.2–3705.2)
CD19+ 605.1 229.8
(147.5–6566.1) (50.8–2147.5) 0.006
R coeficient=0.68, p=0.015
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Fig. 7. Correlation between CD4+/CD25high cell count and the
total number of dendritic cells (TDCs) in synovial fluid (SF) from
children with JIA.
Medians and ranges are shown.
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suggests an indirect relationship between the activation
of apoptosis in circulating lymphocytes and recruitment
of BDCs from the peripheral blood to the SF and their
accumulation in the latter compartment. It is thus likely
that apoptotic bodies containing DNA fragments
derived from disintegrating lymphocytes are abstracted
by APCs, including BDCs. In turn, BDCs migrate to tis-
sues, including joints and joint-draining lymph nodes,
where they mature and may present lymphocytic
autoantigens [18], including apoptotic cell-derived DNA
fragments [22], and trigger cytokine responses of T and
B cells. This may maintain prolonged autoimmune
inflammation with subsequent pannus formation and
joint destruction. Our current data provide another
argument supporting this thesis, since increased periph-
eral blood lymphocyte apoptosis significantly correlated
with high TNF-α concentration in JIA SF.
We also found significant enrichment of SF with
T cells, predominantly CD4+ lymphocytes. Similar data
were previously reported regarding RA [1, 17]. T cells
within the SF of patients with JIA appeared to have
a phenotype that would support selective recruitment
from the blood [17]. Thus highly differentiated T cells,
which have increased capacity to migrate across
inflamed endothelium, may be selectively recruited to
the joint. This process itself may alter the expression of
activation markers on the cells in the absence of cell
proliferation [1]. In the rheumatoid joint enriched with
DCs, interaction of DCs and CD4+ T cells can therefore
be highly augmented. Moreover, IL-15 was found to
potently increase the proliferation of T-cell subsets [16].
In light of our previous report [24] showing a highly
increased concentration of IL-15 in JIA SF, this may be
a possible mechanism promoting SF T-cell expansion in
JIA.
Moreover, we observed significant enrichment of
JIA SF with CD4+/CD25high cells, considered to be pre-
dominantly T-regulatory cells (Tregs). Analysis of
FoxP3 mRNA levels revealed a high expression in SF
CD4+CD25bright T cells in JIA [5]. Here we showed that
high numbers of CD4+/CD25high cells corresponded with
enlarged numbers of BDCs and strongly suggest an
active interaction between these cells in JIA SF. Tregs,
enriched in the SF of patients with RA, were found to be
capable of suppressing CD4 T-cell proliferation in vitro
[15]. In the RA synovium, Tregs might be inhibited by
several factors, such as inflammatory cytokines, includ-
ing TNF-α, or stimulated by APCs, such as DCs. This
may allow synovial inflammation to evolve and persist
despite the enhanced frequencies of synovial Tregs. 
In this study we did not assess differences in
CD4+/CD25high cells between peripheral blood JIA and
healthy controls. Wei et al. [27], however, reported
a decreased frequency of peripheral blood regulatory
T cells, corresponding to a lower level of CTLA-4
expression on their surface, which may additionally indi-
cate their important role in the immunoregulation of
JIA. Similarly, Cao et al. [2] showed significant reduc-
tion in CD4+/CD25high cells in RA peripheral blood with
their enrichment in the joint in RA patients. These data
suggest recruitment of regulatory T cells to the joints
affected by the JIA or RA inflammatory process. 
Interestingly, the absolute numbers of CD19+ cells
were significantly lower in SF than in JIA peripheral
blood, which was in accord with earlier observations in
RA [17]. This might be due to an imbalance between T-
and B-cell populations in SF. There is much evidence
that B cells also play an important role in RA develop-
ment; namely, autoreactive B cells can be driven by
T cells to produce IgG autoantibodies that may be
directly involved in joint damage, and B cells are known
to be crucial in activating CD4+ T cells [13]. 
Finally, it is important to mention that all the above
data were collected for the first time for JIA by the high-
ly accurate, repeatable, and direct method of cell enu-
meration by flow cytometry (“single-platform” assay).
This method, recently introduced for DC enumeration
by Ma et al. [19], seems to be the most reliable for quan-
titative assessment of different biological phenomena. 
In conclusion, spontaneous apoptosis of peripheral
blood lymphocytes correlates with enhanced number of
BDCs in SF as well SF TNF-α concentration in children
with JIA. Simultaneously, JIA SF is significantly
enriched with T lymphocytes, including CD4+/CD25high
cells. These data support the thesis about a possible
pathogenic link between impaired apoptosis of periph-
eral blood/SF lymphocytes, BDC recruitment to SF, and
other key elements of the immune system (e.g. T-cell
activation, cytokine production, and impairment of Treg
function) in JIA.
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